shutterstock_406580500_jonathan_weiss
Jonathan Weiss / Shutterstock.com
22 October 2020AmericasMuireann Bolger

Eli Lilly’s Dermira accuses Perrigo of infringing patents

Pharmaceutical company Eli Lilly’s subsidiary Dermira has accused generic drugmaker Perrigo of infringing eight patents for Qbrexza, a prescription-only cloth towelette approved to treat  hyperhidrosis, a condition that causes excessive underarm sweating.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
23 August 2016   AstraZeneca and Eli Lilly have received US Food and Drug Administration fast track designation for the development of a treatment for Alzheimer’s.
Americas
16 February 2015   The Canadian government has given a scathing assessment of Eli Lilly’s patenting practices in its formal response to the pharmaceutical company’s CAD $500 million lawsuit against it.